|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-1-21
|
|
pubmed:abstractText |
The autoantigen in Goodpasture's syndrome is known to be contained within the non-collagenous (NC1) domain of type IV collagen. We have examined the specificity of autoantibodies to glomerular basement membrane (GBM) using the technique of 2-D electrophoresis followed by Western blotting. Protein stains of 2-D gels of collagenase-digested human GBM revealed extensive charge and size heterogeneity. Major components were of mol. wt 24-30 kD and 43-56 kD, corresponding to monomeric and dimeric subunits of NCl. Western blotting of 2-D gels with IgG from patients with anti-GBM disease demonstrated that the most antigenic components migrated as cationic 28-kD monomers (pI 10) and similarly charged dimers, although other components were recognized less strongly. The mobility of the strongly antigenic polypeptides was different to that of the known alpha 1 and alpha 2 chains of type IV collagen. Autoantibodies from all 20 patients studied showed the same pattern of reactivity, regardless of their clinical features (in particular, the presence or absence of pulmonary haemorrhage) or HLA type. A monoclonal antibody (P1) to human GBM bound in a similar pattern, particularly recognizing the cationic components. 2-D gels of affinity-purified GBM from a P1 column showed enrichment of the 28-kD monomers, which were recognized by human autoantibodies on Western blotting. These results demonstrate that the autoimmune response in Goodpasture's syndrome is of restricted specificity, and support the suggestion that the major autoantigenic determinant is present on the novel alpha 3 chain of type IV collagen.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-1689491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-1690255,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-1856232,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-1985905,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2317378,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2349482,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2438283,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2671489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2925692,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-2985699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3198637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3288737,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3374833,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3392020,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3417661,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3528615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3540450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3652534,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-3782134,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-388439,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-4068032,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-4630462,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-4964566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-6140495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-6172996,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-6274634,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-6328527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1747953-6642729
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0009-9104
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
457-63
|
|
pubmed:dateRevised |
2010-8-25
|
|
pubmed:meshHeading |
pubmed-meshheading:1747953-Adolescent,
pubmed-meshheading:1747953-Adult,
pubmed-meshheading:1747953-Aged,
pubmed-meshheading:1747953-Anti-Glomerular Basement Membrane Disease,
pubmed-meshheading:1747953-Antibody Specificity,
pubmed-meshheading:1747953-Autoantibodies,
pubmed-meshheading:1747953-Autoimmune Diseases,
pubmed-meshheading:1747953-Blotting, Western,
pubmed-meshheading:1747953-Collagen,
pubmed-meshheading:1747953-Electrophoresis, Gel, Two-Dimensional,
pubmed-meshheading:1747953-Female,
pubmed-meshheading:1747953-Glomerular Mesangium,
pubmed-meshheading:1747953-Humans,
pubmed-meshheading:1747953-Male,
pubmed-meshheading:1747953-Middle Aged
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional western blotting.
|
|
pubmed:affiliation |
Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
